Clifford Berkman.Cliff Berkman, professor, chemistry, co-authored “First-in-Human Phase I study of CTT1057, a Novel 18F Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate Specific Membrane Antigen in Prostate Cancer” in Journal of Nuclear Medicine.